Michigan orthopedic and MSK practices that develop or advocate for specialty-specific quality measures have a narrow window to shape the 2026 MIPS quality landscape. Submitting orthopedic-relevant measures now influences what metrics will be available for reporting in future performance years.
This is a structural shift in how Medicare reimburses orthopedic surgical care. Michigan MSK practices and ASCs should audit their procedure mix, update site-of-service designations, and prepare quality reporting under new outpatient APC classifications as the IPO migration accelerates toward 2029.
MARCQI VBR performance directly affects financial reimbursement for Michigan orthopedic surgeons performing hip and knee replacement. Reviewing 2026 measures now — at the start of the measurement year — allows surgeons and quality teams to course-correct early and maximize payout in 2027.
The MSQC Frailty Project is directly relevant to Michigan orthopedic practices, where pre-operative frailty screening improves surgical risk stratification for MSK and joint replacement patients. The SUCCESS catheter care project also touches post-surgical infection prevention protocols applicable to orthopedic hospital settings.
Michigan orthopedic hospitals and ASCs that have built compliance workflows around the former NPSG numbering and structure must update internal audit tools, staff education, and documentation to reflect the 2026 NPG framework ahead of any Joint Commission survey activity this year.
The mandatory outcome measure requirement raises the performance bar for Michigan orthopedic surgeons reporting under the joint repair MVP. Practices that previously met requirements without an outcome measure must adjust their quality measure selection for the 2026 performance year to remain compliant and avoid MIPS penalties.
Michigan orthopedic hospitals should remove the four retired measures from their quality dashboards and reporting workflows to reduce administrative burden and reallocate resources toward actively scored metrics. Facilities should also begin planning for the 2028 ED timeliness measure transition.
As Michigan orthopedic practices adopt AI-assisted imaging, diagnostic, and surgical planning tools, ECRI's warning about automation bias and lack of governance is directly applicable. Practices using AI diagnostics without formal oversight protocols face elevated liability and patient safety risk.
Michigan orthopedic hospitals can now benchmark their PSI performance directly against national safety data on the public dashboard, creating new transparency and accountability expectations. Leadership should proactively review their facility's position before payers or accreditors reference the dashboard in negotiations or surveys.
Wrong-site and wrong-patient surgical events — cardinal "never events" in orthopedics — remain prominently featured in the updated SRE list. Michigan orthopedic facilities should review the crosswalk document now to assess which internal sentinel event categories and reporting workflows will require updating ahead of the January 2027 effective date.
Threshold stability through 2028 gives Michigan orthopedic practices reliable planning targets for MIPS compliance over the next three performance years. The revised claims-based scoring methodology may affect individual measure scores and should be reviewed with your MIPS reporting consultant or registry.
THA/TKA readmissions remain an explicit HRRP target condition, making 30-day readmission reduction a direct financial priority for Michigan orthopedic practices and their hospital partners. Facilities whose readmission rates from 2021–2024 were elevated will see payment penalties in FY 2026 and should be actively managing their 2025–2026 readmission improvement trajectory now.